Overview / Abstract: |
This Clinical Commentary consists of an HD video roundtable discussion with two leading expert psychiatrists in the field, who participate in a panel discussion of tardive dyskinesia (TD) as a widespread and undertreated condition in psychiatric populations, as well as the importance of evidence-based differential diagnostics, newly approved therapeutics for treatment of the condition, and strategies for both personalized and improved patient care. This activity additionally includes an interview with a leading neurologist who reviews diagnostic algorithms for TD and shares her perspective on the impact of new drug approvals and strategies for working together with psychiatrists in managing patients with TD. Throughout the activity, testimonials of a patient with tardive dyskinesia are incorporated to bring relevance to the patient perspective, experience and treatment goals. Tardive dyskinesia (TD) is a medication-induced, disabling, and often-permanent neurological, hyperkinetic movement-disorder syndrome. TD has significant impact on patients’ activities of daily living (ADLs) and overall quality of life. Physicians require education and awareness on diagnostic algorithms for TD, on agents newly approved for its treatment, and on the associated risks/benefits of those agents’ use in the TD population based on the most recent clinical data and evidence. Upon completion of this activity, participants will be able to: |
Expiration |
Aug 31, 2019 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Psychology CE, Social Work CE |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.0 |
Accreditation |
ACCME |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
Cynthia Comella, MD Christoph Correll, MD John Kane, MD |
Activity Specialities / Related Topics |
Adverse Drug Reactions / ADR, Behavioral Medicine, Depression / Bipolar, Education / Teaching, Family Medicine, Internal Medicine, Language Disorders / Aphasia, Neurology, Psychiatry / Mental Health, Speech Language Pathology |
Sponsors / Supporters / Grant Providers |
Sponsored by the Academy for Continued Healthcare Learning (ACHL). Supported by an educational grant from Neurocrine BioSciences. |
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Webcasts, Newsletter, Case Study, Live Meetings, Slidekit, Monograph, Journal, Tardive dyskinesia, TD, Dyskinesia, psychiatry, neurology, dopamine antagonist, Dopamine Receptor-Blocking Agents, antipsychotics, KINECT 4, INGREZZA, valbenazine, deutetrabenazine, Neurocrine Biosciences, Neurocrine, Christoph Correll, Correll, Comella, Cynthia Comella Free CE CME Live CE CME |